These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36941616)

  • 21. Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
    Ocan M; Nakalembe L; Otike C; Omali D; Buzibye A; Nsobya S
    Malar J; 2023 May; 22(1):165. PubMed ID: 37237283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics.
    Mbonye AK; Birungi J; Yanow S; Magnussen P
    BMC Infect Dis; 2013 May; 13():237. PubMed ID: 23702003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
    Watsierah CA; Ouma C
    Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and predictors of malaria care-seeking, diagnostic testing, and artemisinin-based combination therapy for children under five with fever in Northern Nigeria: a cross-sectional study.
    Millar KR; McCutcheon J; Coakley EH; Brieger W; Ibrahim MA; Mohammed Z; Bassi A; Sambisa W
    Malar J; 2014 Nov; 13():447. PubMed ID: 25413231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
    Wasunna B; Okiro EA; Webster J; Todd J; Snow RW; Jones C
    PLoS One; 2015; 10(7):e0130305. PubMed ID: 26135143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of febrile children under five years in hospitals and health centres of rural Ghana.
    Webster J; Baiden F; Bawah J; Bruce J; Tivura M; Delmini R; Amenga-Etego S; Chandramohan D; Owusu-Agyei S
    Malar J; 2014 Jul; 13():261. PubMed ID: 25008574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
    Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Nombré Y; Dianda F; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
    Malar J; 2022 May; 21(1):155. PubMed ID: 35637506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania.
    Kamat VR; Nyato DJ
    Malar J; 2010 Feb; 9():61. PubMed ID: 20187949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
    Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
    Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
    Assefa DG; Yismaw G; Makonnen E
    Malar J; 2021 Aug; 20(1):340. PubMed ID: 34384431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
    Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
    Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
    Amuasi JH; Diap G; Nguah SB; Karikari P; Boakye I; Jambai A; Lahai WK; Louie KS; Kiechel JR
    PLoS One; 2012; 7(10):e47733. PubMed ID: 23133522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low use of artemisinin-based combination therapy for febrile children under five and barriers to correct fever management in Benin: a decade after WHO recommendation.
    Damien BG; Aguemon B; Abdoulaye Alfa D; Bocossa D; Ogouyemi-Hounto A; Remoue F; Le Hesran JY
    BMC Public Health; 2018 Jan; 18(1):168. PubMed ID: 29357869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda.
    Ndagije HB; Kiguba R; Manirakiza L; Kirabira E; Sserwanga A; Nabirye L; Mukonzo J; Olsson S; Spinewine A; D'Hoore W; Speybroeck N
    Malar J; 2020 Feb; 19(1):63. PubMed ID: 32041619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
    Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
    Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
    Ladner J; Davis B; Audureau E; Saba J
    Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with access and adherence to artemisinin-based combination therapy (ACT) for children under five: a secondary analysis of a national survey in Sierra Leone.
    Banek K; Webb EL; Doogue EB; Smith SJ; Chandramohan D; Staedke SG
    Malar J; 2021 Jan; 20(1):56. PubMed ID: 33478507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
    Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
    Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.